Ledger.Open graph →
SEC Form D · filed February 23, 2024

Autolus Therapeutics plc

Offering
$200.0M
Sold
$200.0M
Exemption
Rule 506(b)
Industry
Other
Location
London, United Kingdom
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (35)

William D. Young · Cambridge, MADirectorCynthia H. Butitta · London, United KingdomDirectorRobert H. Azelby · London, United KingdomDirectorElisabeth H. Leiderman · London, United KingdomDirectorChristian Itin · London, United KingdomExec · DirectorWilliam D. Young · Portsmouth, NHDirectorEdgar Braendle · London, United KingdomExecMartin H. Murphy · London, United KingdomDirectorLinda H. Bain · London, United KingdomDirectorChristopher Vann · London, United KingdomExecMartin Pule · London, United KingdomExecDavid Brochu · London, United KingdomExecJoseph H. Anderson · London, United KingdomDirectorRobert H. Iannone · London, United KingdomDirectorJohn H. Berriman · London, United KingdomDirectorJohn H. Johnson · Costa Mesa, CADirectorBrent Rice · London, United KingdomExecRobert Dolski · London, United KingdomExecChristian Itin · London, United KingdomExec · DirectorWilliam D. Young · South San Francisco, CADirectorEdgar Braendle · London, United KingdomExecMartin H. Murphy · London, United KingdomDirectorLinda H. Bain · London, United KingdomDirectorChristopher Vann · London, United KingdomExecMartin Pule · London, United KingdomExecCynthia H. Butitta · London, United KingdomDirectorRobert H. Azelby · London, United KingdomDirectorDavid Brochu · London, United KingdomExecJoseph H. Anderson · London, United KingdomDirectorRobert H. Iannone · London, United KingdomDirectorJohn H. Berriman · London, United KingdomDirectorJohn H. Johnson · Costa Mesa, CADirectorElisabeth H. Leiderman · London, United KingdomDirectorBrent Rice · London, United KingdomExecRobert Dolski · London, United KingdomExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗